Add the extracellular matrix in your 3D cellular assays

BIOMIMESYS® 3D technology is a natural HA-based scaffold to better mimic the tissue microenvironment and provide more predictive tools for drug development. The BIOMIMESYS® products are formed by crosslinking reaction of hydrosoluble modified hyaluronic acid and others matrix components with ADH (adipic acid dihydrazide), to mimic the extracellular matrix (ECM). Depending on the organ, ECM components vary and are present in different proportions, allowing a more or less dense and compact cellular environment. BIOMIMESYS® 3D technology allows us to reproduce the cell microenvironment of each organ.

Click here to get more information!

BIOMIMESYS® Brain
BIOMIMESYS® Brain
BIOMIMESYS® Liver
BIOMIMESYS® Liver
BIOMIMESYS® Oncology
BIOMIMESYS® Oncology
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Custom

R&D programs and partnerships

We are involved in amazing projects to improve medical and biological science, thanks to partners all around the world. Click on a project to get more information.
CHOlesterol Personalized INnovation (CHOPIN)

RHU CHOPIN

To ensure personalised treatment for familial hypercholesterolemia

ONCO3D

ONCO3D

To develop relevant 3D models of different tumors, in order to better assess the efficiency of anticancer therapies.

Nanosteam

Nanosteam

A holistic approach to address brain delivery

NEUROCELL3D

NEUROCELL3D

Face to the high failure of drug candidate in clinical trial, in particular involving the brain, we goal to develop more relevant and more predictive in vitro models for preclinical assessment, in the aim to early select molecules of interest, in term of efficacy and safety.

BioPharMEMS

BioPharMEMS

To design and industrialize new pharmacological in vitro assays for the screening of compounds/biopharmaceuticals in 3D

ScaLABle-MEAT

ScaLABle-MEAT

To develop the technological platform to produce lab-grown meats. The project is funded by EUREKA and the national funding agencies associated with the Eurostars program.

MIMLIVEROnChip

MIMLIVEROnChip

To develop a universal “plug-and-play” liver-on-chip platform mimicking the major events occurring in the liver sinusoid in order to predict the hepatoxicity of drugs.

VisuAI

VisuAI

To explore the use of AI technologies to improve different steps of 3D biological picture exploitation

News

Last news from HCS Pharma and biotechnologies!

Artificial intelligence to improve 3D cell culture : a milestone for HCS pharma

As you may now, in HCS Pharma we strongly believe that the critical point of the human health evolution in next years is the in vitro 3D cell culture, especially for complex diseases like cancer [1]. It’s why we work hard on our exclusive BIOMIMESYS® technology. As experts in HCS and cell imaging, we must master all the process : 3D biological models, 3D cell culture, volumetric pictures acquisition, 3D reconstruction and segmentation of cells and ECM compounds, 3D parameters extraction and, of course, biological interpretations. As explained in our VisuAI R&D project, the 3D reconstruction and segmentation step is not simple.

  • Hello tomorrow deep tech

Get in Touch

How can we help you?

Find us at the office

HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
See on map

Give us a ring

+33 769 999 137
Only for customers please, if you have another interest use the form contact.

Contact Us